Ledger.Open graph →
SEC Form D · filed December 13, 2017

Metacrine, Inc

Offering
$22.0M
Sold
$22.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Ronald Evans · San Diego, CADirectorRichard Heyman · San Diego, CADirectorRobert Adelman · San Diego, CADirectorKristina Burow · San Diego, CADirectorKen Song · San Diego, CAExec · DirectorWilliams M. Clark · Austin, TXDirectorLawrence C. Mandes · DENVER, CODirectorMatthew Ginsberg · Eugene, ORDirectorAlaina Danley · Grand Cayman, Cayman IslandsDirectorEric Stewart · Robinson, ILExec · DirectorAmir Nashat · Cambridge, MADirectorPatricia Millican · San Diego, CAExecCarol Gallagher · San Diego, CADirectorLilly J. Farahnakian · Chicago, ILDirectorDennis Capovilla · Eugene, ORDirectorJames Deters · DENVER, CODirectorMurray Markiles · Sherman Oaks, CADirectorMichael Hylander · San Diego, CAExec · DirectorAmir Nashat · San Diego, CADirectorPatricia Millican · San Diego, CAExecCarol Gallagher · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗